The per patient cost for this drug was $366,496 in 2014. This Coagulation Factor IX drug is used to control and prevent bleeding in patients with hemophilia B. The cost per patient in 2014 was $302,364.
Table of Contents
How much does factor 9 cost?
The per patient cost for this drug was $366,496 in 2014. This Coagulation Factor IX drug is used to control and prevent bleeding in patients with hemophilia B. The cost per patient in 2014 was $302,364.
What does Eloctate treat?
ELOCTATE, Antihemophilic Factor (Recombinant), Fc Fusion Protein, is a recombinant DNA derived, antihemophilic factor indicated in adults and children with Hemophilia A (congenital Factor VIII deficiency) for: On-demand treatment and control of bleeding episodes. Perioperative management of bleeding.
Who manufactures Eloctate?
Manufacturer: Biogen Idec, Inc.
Who owns Eloctate?
Sanofi picked up Eloctate in last year’s $11.6 billion buyout of hemophilia-focused Bioverativ. The deal was one of several moves by the French drugmaker intended to shift the company away from a reliance on primary care and bring it further into rare diseases.
Is hemophilia treatment expensive?
Treatment for hemophilia is extremely expensive. This is a lifetime expense. The average cost is $40,000 to $50,000 a year. Complications from hemophilia can bring further expenses, which may be over $100,000.
Why is treatment for hemophilia so expensive?
Not only do prices rise steadily as each new product comes on the market, demand is growing — and pushing costs upward — as more and more clotting factor is used to prevent bleeding episodes, not just to treat them.
How is Eloctate administered?
Perform intravenous bolus infusion. The rate of administration should be determined by the patient’s comfort level, and no faster than 10 ml per minute. After infusing ELOCTATE, remove and properly discard the infusion set.
When was Eloctate FDA approved?
Development Timeline for Eloctate
| Date | Article |
|---|---|
| Jun 6, 2014 | Approval FDA Approves Eloctate – first Antihemophilic Factor, Fc Fusion Protein for Patients with Hemophilia A |
What are the costs of hemophilia?
The cost of drug therapy for a person with hemophilia can be several hundred thousand dollars per year and annual treatment costs of $1 million or more are not unheard of for patients with the most severe forms of the disease.
Why is hemophilia so expensive?
How expensive is it to treat hemophilia?
How much does hemophilia cost?